BEHRNDT-ERIKSEN MADS NIKOLAJ enters HEMAB THERAPEUTICS HOLDINGS, INC. with 87.12K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 4/30/2026ACC: 0001193125-26-198200
Officer· See Remarks
Since Apr 2026
87.12K
Baseline shares
0.00
Direct ownership
0 positions
424.71K
Derivative underlying
3 instruments
2
Security positions
87.12K indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned50.60K
Common Stock
IndirectShares owned36.52K
Total
87.12K indirect87.12K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 50.60K | Indirect |
| Common Stock | 36.52K | Indirect |
| Total | 87.12K | 87.12K indirect |
Derivative Holdings3
Warrants (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
195.21K
Shares owned
N/A
Exercise price
6.00
Expiration
—
Exercise window
—
Warrants (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
134.53K
Shares owned
N/A
Exercise price
7.07
Expiration
—
Exercise window
—
Warrants (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
94.97K
Shares owned
N/A
Exercise price
2.16
Expiration
—
Exercise window
—
Total
Underlying
424.71K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants (Right to Buy) Direct | Common Stock | 6.00 | — | — | 195.21K | N/A |
| Warrants (Right to Buy) Direct | Common Stock | 7.07 | — | — | 134.53K | N/A |
| Warrants (Right to Buy) Direct | Common Stock | 2.16 | — | — | 94.97K | N/A |
| Total | 424.71K | 0.00 | ||||